Asian press release distribution

Press Releases for Thursday, June 21, 2018

TRI、オープンソースの自動運転シミュレーター開発を支援 21:00 HKT/SGT

Verisk Acquires Validus-IVC 19:30 HKT/SGT

On 21 June 2018 Republic of Srpska Opens Order Book for Eurobond Placement of up to EUR200 Million 15:30 HKT/SGT

FURUYA金屬：於土浦工廠（茨城縣土浦市澤邊）進行釕精製產能擴產的投資計劃 15:00 HKT/SGT

FURUYA金属：对土浦工厂（茨城县土浦市泽边）实施钌精炼产能扩增的投资 15:00 HKT/SGT

Furuya Metal to Invest in Enhancing the Ruthenium Refining Capability of Tsuchiura Plant 15:00 HKT/SGT

NEC Establishes NEC Laboratories India 14:01 HKT/SGT

富士通と理研、ポスト「京」開発状況について 14:00 HKT/SGT

TOYOTA、コースターを一部改良 13:30 HKT/SGT

三菱自、株主総会で「グリーン電力証書システム」を活用 13:30 HKT/SGT

Fujitsu Completes Post-K Supercomputer CPU Prototype, Begins Functionality Trials 13:19 HKT/SGT

Mitsubishi Corporation Named Preferred Bidder for Offshore Transmission Asset in the UK 12:00 HKT/SGT

三菱商事、英国海底送電事業の優先交渉権獲得について 11:30 HKT/SGT

Tubatu, China's No.1 online home renovation platform may seek listing in Hong Kong soon upon Qeeka Home's IPO 11:07 HKT/SGT

NECとインテージ、食品ロス・廃棄の解決に向け、バリューチェーン全体で需給を最適化するビジネスで協業 11:00 HKT/SGT

HKBU scholars invent award-winning medical device for safe growth of neural stem cells using nanotechnology 11:00 HKT/SGT

Kintaro Cells Power establishes new partnership with Tokyo Medical University to advance stem cell research 10:50 HKT/SGT

Follow the cookie crumbs and discover DoubleTree Hotel & Resorts in Malaysia 10:30 HKT/SGT

NEC、Windows 10移行・運用支援をベースに働き方改革、セキュリティ対策をトータルサポート 10:00 HKT/SGT

AbbVie and Eisai Announce the Launch of HUMIRA for Subcutaneous Injection 20 mg Syringe 0.2 mL 09:51 HKT/SGT

高博（Globle）：讓概念成為現實的以社區共享為驅動的革命性創新平台 09:07 HKT/SGT

高博（Globle）：让概念成为现实的以社区共享为驱动的革命性创新平台 09:05 HKT/SGT

Integrating MathWorks MATLAB and Microsoft Dynamics 365 Using Hitachi's Lumada IoT Platform 08:33 HKT/SGT

CLX Ranked Best Messaging Vendor in North America 08:30 HKT/SGT

ACN Search:

Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575